SPI联合GSL与GT治疗晚期原发性闭角型青光眼的三年多中心结果
这项多中心前瞻性观察研究纳入70眼(58例)无白内障的晚期原发性闭角型青光眼,评估SPI+GSL+GT联合手术的3年疗效与安全性。结果显示眼压从基线29.4±8.1 mmHg降至36个月16.4±4.01 mmHg(降幅40.7±18.8%,p<0.001),抗青光眼药物从2.0±1.4降至0.7±0.9(p<0.001),完全与合格累积成功率分别为54.3%与84.3%,视野MD稳定,无威胁视力事件。
要点
- 联合手术3年眼压显著下降且抗青光眼药物用量减少65.7%。
- 3年完全与合格累积成功率分别为54.3%与84.3%。
- 主要晚期并发症为需手术的白内障(10眼)和持续性PAS(11眼)。
核心结论
- SPI+GSL+GT联合手术在无白内障的晚期PACG中提供持续3年的眼压下降、稳定视功能及良好安全性。
研究设计与样本
- 多中心前瞻性观察研究,纳入完成36个月随访的晚期PACG无白内障患者70眼(58例)。
主要发现
- 基线平均眼压29.4±8.1 mmHg降至36个月16.4±4.01 mmHg,降幅40.7±18.8%(p<0.001)。
- 抗青光眼药物从2.0±1.4降至0.7±0.9(p<0.001),术后所需药物减少65.7%。
- 3年完全与合格累积成功率分别为54.3%与84.3%。
- 中位BCVA从0.00恶化至0.10 logMAR(p<0.001),21.4%眼出现≥2行Snellen视力下降,归因于白内障进展。
- 视野MD保持稳定(p=0.217);主要晚期并发症为需手术的白内障(10眼)和持续性PAS(11眼),无威胁视力事件;年龄较大与3年手术成功率较高相关(p<0.05)。
临床怎么用
- 对于无白内障的晚期PACG,可考虑SPI+GSL+GT联合手术作为长期控制眼压的可靠选择。
- 术后需监测白内障进展及PAS持续情况,并关注年龄对手术成功率的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To assess the 3-year efficacy and safety of combined surgical peripheral iridectomy (SPI), goniosynechialysis (GSL) and goniotomy (GT) for advanced primary angle-closure glaucoma (PACG) without cataract. METHODS: This was a multicentre prospective observational study with extended follow-up. We enrolled advanced PACG without cataract patients who underwent combined SPI+GSL+ GT and completed 36-month follow-up. Key outcomes included changes in intraocular pressure (IOP), best-corrected visual acuity (BCVA), usage of anti-glaucoma medications, surgical success rates, progression of peripheral anterior synechiae (PAS), endothelial cell density, visual field (VF) mean deviation (MD) and long-term postoperative complications. RESULTS: A total of 70 eyes from 58 patients were included in the final analysis. Baseline mean IOP (29.4±8.1 mm Hg) decreased to 16.4±4.01 mm Hg at 36 months (40.7±18.8% reduction, p<0.001), with anti-glaucoma medications declining from 2.0±1.4 to 0.7±0.9 (p<0.001), representing a 65.7% reduction in required medications postoperatively. At the 3-year follow-up, the cumulative complete and qualified success rates were 54.3% and 84.3%, respectively. Median BCVA worsened slightly (0.00 vs 0.10 logarithm of the minimum angle of resolution, p<0.001); 21.4% of eyes had significant vision loss (≥2 Snellen lines), attributable to cataract progression. MD of VF remained stable (p=0.217). Main late complications were cataract requiring surgery (n=10) and persistent PAS (n=11), with no vision-threatening events. Older age correlated with higher 3-year surgical success (p<0.05). CONCLUSIONS: Combined SPI+GSL+GT provides sustained IOP reduction, stable visual function, and a favourable safety profile over 3 years, supporting its role as a reliable long-term treatment for advanced PACG without cataract.
引用
- Lin F, Tang L, Zhu X, et al. Three-year outcomes of combined surgical peripheral iridectomy, goniosynechialysis and goniotomy for advanced primary angle-closure glaucoma: a multicentre study. Br J Ophthalmol. 2026. PMID: 42833871. doi:10.1136/bjo-2026-329527
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。